- Home
- PRAX vs MTAL Comparison
PRAX vs MTAL Comparison
Compare PRAX & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- MTAL
- Stock Information
- Founded
- PRAX 2015
- MTAL 2021
- Country
- PRAX United States
- MTAL Jersey
- Employees
- PRAX N/A
- MTAL N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- MTAL Blank Checks
- Sector
- PRAX Health Care
- MTAL Finance
- Exchange
- PRAX Nasdaq
- MTAL Nasdaq
- Market Cap
- PRAX 599.7M
- MTAL 690.2M
- IPO Year
- PRAX 2020
- MTAL 2021
- Fundamental
- Price
- PRAX $38.55
- MTAL $12.16
- Analyst Decision
- PRAX Strong Buy
- MTAL Hold
- Analyst Count
- PRAX 10
- MTAL 2
- Target Price
- PRAX $116.50
- MTAL $14.00
- AVG Volume (30 Days)
- PRAX 320.6K
- MTAL 634.7K
- Earning Date
- PRAX 05-02-2025
- MTAL 04-29-2025
- Dividend Yield
- PRAX N/A
- MTAL N/A
- EPS Growth
- PRAX N/A
- MTAL N/A
- EPS
- PRAX N/A
- MTAL N/A
- Revenue
- PRAX $8,122,000.00
- MTAL $340,736,000.00
- Revenue This Year
- PRAX N/A
- MTAL $21.07
- Revenue Next Year
- PRAX N/A
- MTAL $19.84
- P/E Ratio
- PRAX N/A
- MTAL N/A
- Revenue Growth
- PRAX 270.02
- MTAL 114.30
- 52 Week Low
- PRAX $26.70
- MTAL $7.69
- 52 Week High
- PRAX $91.83
- MTAL $14.93
- Technical
- Relative Strength Index (RSI)
- PRAX 53.72
- MTAL 75.84
- Support Level
- PRAX $35.21
- MTAL $9.88
- Resistance Level
- PRAX $38.90
- MTAL $12.48
- Average True Range (ATR)
- PRAX 2.09
- MTAL 0.29
- MACD
- PRAX 0.07
- MTAL 0.28
- Stochastic Oscillator
- PRAX 69.58
- MTAL 80.49
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About MTAL Metals Acquisition Limited
MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.